L. Hoffart

Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature

Anterior segment uses of bevacizumab

Long-term (60-month) results for the implantable miniature telescope: efficacy and safety outcomes stratified by age in patients with end-stage age-related macular degeneration

Systemic and Ocular Safety of Intravitreal Anti-VEGF Therapies for Ocular Neovascular Disease

Hypoxia-Inducible Factor-Dependent Expression of Angiopoietin-Like 4 by Conjunctival Epithelial Cells Promotes the Angiogenic Phenotype of Pterygia.

Cataracts

Hématomes maculaires après injections intravitréennes d’anti-VEGF pour dégénérescence maculaire liée à l’âge : série rétrospective

Corneal Endothelial Cell Loss After Cataract Extraction by Using Ultrasound Phacoemulsification Versus a Fluid-based System

Inhibition of corneal neovascularization after alkali burn: comparison of different doses of bevacizumab in monotherapy or associated with dexamethasone